{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:19:07Z","timestamp":1789604347611,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jns.2022.120324","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T10:58:50Z","timestamp":1655463530000},"page":"120324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms"],"prefix":"10.1016","volume":"439","author":[{"given":"B.E.","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Celikbilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.T.","family":"Saltoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Konar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hizmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120324_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13054-020-03200-1","article-title":"Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000000897","article-title":"Potential neurologic manifestations of COVID-19","volume":"11","author":"Nordvig","year":"2021","journal-title":"Neurol. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41582-020-00453-w","article-title":"Neurological infection with SARS-CoV-2 - the story so far","volume":"17","author":"Solomon","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12974-021-02323-8","article-title":"Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19","volume":"18","author":"Savarraj","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jns.2022.120324_bb0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.jns.2022.120324_bb0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2022.120324_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120162","article-title":"Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis","volume":"434","author":"Premraj","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ane.13266","article-title":"Neurological manifestations of COVID-19: a systematic review and current update","volume":"142","author":"Whittaker","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2022.120324_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2022.120324_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116832","article-title":"Central nervous system manifestations of COVID-19: a systematic review","volume":"413","author":"Asadi-Pooya","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0060","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1212\/WNL.0000000000010977","article-title":"CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series","volume":"96","author":"Ed\u00e9n","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120324_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijid.2020.10.044","article-title":"Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development","volume":"102","author":"Esp\u00edndola","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jns.2022.120324_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19","volume":"95","author":"Kanberg","year":"2020","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.jns.2022.120324_bb0075","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1007\/s00415-021-10517-6","article-title":"Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19","volume":"268","author":"Aamodt","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120324_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103512","article-title":"Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up","volume":"70","author":"Kanberg","year":"2021","journal-title":"EBioMedicine."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0085","doi-asserted-by":"crossref","first-page":"18665","DOI":"10.1038\/s41598-020-75618-0","article-title":"Serum S100B protein as a marker of severity in Covid-19 patients","volume":"10","author":"Aceti","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jns.2022.120324_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pjnns.2018.02.002","article-title":"Looking for novel, brain-derived, peripheral biomarkers of neurological disorders","volume":"52","author":"Chmielewska","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"issue":"4","key":"10.1016\/j.jns.2022.120324_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12975-010-0040-6","article-title":"Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings","volume":"1","author":"Brunkhorst","year":"2010","journal-title":"Transl. Stroke Res."},{"issue":"6","key":"10.1016\/j.jns.2022.120324_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity."},{"issue":"10","key":"10.1016\/j.jns.2022.120324_bb0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneurol.2016.127","article-title":"Fluid biomarkers for mild traumatic brain injury and related conditions","volume":"12","author":"Zetterberg","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2022.120324_bb0110","article-title":"Quantification of neurological blood-based biomarkers in critically ill patients with coronavirus disease 2019","volume":"2","author":"Cooper","year":"2020","journal-title":"Crit. Care Explor."},{"issue":"12","key":"10.1016\/j.jns.2022.120324_bb0115","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1007\/s00415-021-10595-6","article-title":"Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients","volume":"268","author":"De Lorenzo","year":"2021","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.14574","article-title":"The S100B story: from biomarker to active factor in neural injury","volume":"148","author":"Michetti","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2022.120324_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/790431","article-title":"Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue","volume":"2010","author":"Gon\u00e7alves","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"issue":"6","key":"10.1016\/j.jns.2022.120324_bb0130","first-page":"4855","article-title":"S100B regulates inflammatory response during osteoarthritis via fibroblast growth factor receptor 1 signaling","volume":"18","author":"Zhu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jns.2022.120324_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/656481","article-title":"S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond","volume":"2010","author":"Sorci","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"issue":"5","key":"10.1016\/j.jns.2022.120324_bb0140","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.21873\/invivo.12583","article-title":"Association between S100b levels and COVID-19 pneumonia: a case control study","volume":"35","author":"Mete","year":"2021","journal-title":"In Vivo."},{"issue":"10","key":"10.1016\/j.jns.2022.120324_bb0145","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/ene.14703","article-title":"Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity","volume":"28","author":"Virhammar","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ene.14491","article-title":"Cytokine release syndrome-associated encephalopathy in patients with COVID-19","volume":"28","author":"Perrin","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2022.120324_bb0155","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/jiaa632","article-title":"Upper respiratory tract levels of severe acute respiratory syndrome coronavirus 2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe\/critical coronavirus disease 2019","volume":"223","author":"Yilmaz","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jns.2022.120324_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.jns.2022.120324_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41593-020-00771-8","article-title":"The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice","volume":"24","author":"Rhea","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2022.120324_bb0175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.stemcr.2021.01.016","article-title":"SARS-CoV-2 targets glial cells in human cortical organoids","volume":"16","author":"McMahon","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.jns.2022.120324_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13613-021-00836-2","article-title":"Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality","volume":"11","author":"Lim","year":"2021","journal-title":"Ann. Intensive Care"},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/1354750X.2020.1861099","article-title":"The receptor for advanced glycation end product (RAGE) pathway in COVID-19","volume":"26","author":"Yalcin Kehribar","year":"2021","journal-title":"Biomarkers."},{"key":"10.1016\/j.jns.2022.120324_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease - A systematic review","volume":"107","author":"Heimfarth","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jns.2022.120324_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","article-title":"A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury","volume":"159","author":"Thelin","year":"2017","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.jns.2022.120324_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-2094-7-71","article-title":"Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke","volume":"7","author":"Beer","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2022.120324_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2013.10.067","article-title":"S100B as a glial cell marker in diabetic peripheral neuropathy","volume":"558","author":"Celikbilek","year":"2014","journal-title":"Neurosci. Lett."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:52Z","timestamp":1758384052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S0022510X22001861"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120324","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120324"}}